Literature DB >> 34099895

Control of gene doping in human and horse sports.

Teruaki Tozaki1, Natasha A Hamilton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34099895     DOI： 10.1038/s41434-021-00267-5

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


× No keyword cloud information.
  28 in total

Review 1.  The therapeutic potential of IGF-I in skeletal muscle repair.

Authors:  Yao-Hua Song; Jenny L Song; Patrice Delafontaine; Michael P Godard
Journal:  Trends Endocrinol Metab       Date:  2013-04-27       Impact factor: 12.015

2.  Human erythropoietin gene therapy for patients with chronic renal failure.

Authors:  Yitzhak Lippin; Michal Dranitzki-Elhalel; Einat Brill-Almon; Chava Mei-Zahav; Sarah Mizrachi; Yael Liberman; Adrian Iaina; Eli Kaplan; Eduardo Podjarny; Evelyne Zeira; Menahem Harati; Nicole Casadevall; Noam Shani; Eithan Galun
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

3.  Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.

Authors:  Matthew L Hirsch; Sonya J Wolf; R J Samulski
Journal:  Methods Mol Biol       Date:  2016

4.  A duplex qPCR assay for human erythropoietin (EPO) transgene to control gene doping in horses.

Authors:  Hiu Wing Cheung; Kin-Sing Wong; Venus Y C Lin; Terence S M Wan; Emmie N M Ho
Journal:  Drug Test Anal       Date:  2020-10-14       Impact factor: 3.345

5.  Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.

Authors:  Elisabeth R Barton; Linda Morris; Antonio Musaro; Nadia Rosenthal; H Lee Sweeney
Journal:  J Cell Biol       Date:  2002-04-01       Impact factor: 10.539

6.  Transgene detection by digital droplet PCR.

Authors:  Dirk A Moser; Luca Braga; Andrea Raso; Serena Zacchigna; Mauro Giacca; Perikles Simon
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

7.  Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.

Authors:  Raygene Martier; Jolanda M Liefhebber; Ana García-Osta; Jana Miniarikova; Mar Cuadrado-Tejedor; Maria Espelosin; Susana Ursua; Harald Petry; Sander J van Deventer; Melvin M Evers; Pavlina Konstantinova
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-11

8.  NFL is a marker of treatment response in children with SMA treated with nusinersen.

Authors:  Bob Olsson; Lars Alberg; Nicholas C Cullen; Eva Michael; Lisa Wahlgren; Anna-Karin Kroksmark; Kevin Rostasy; Kaj Blennow; Henrik Zetterberg; Már Tulinius
Journal:  J Neurol       Date:  2019-05-23       Impact factor: 4.849

9.  A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA.

Authors:  Eddy N de Boer; Petra E van der Wouden; Lennart F Johansson; Cleo C van Diemen; Hidde J Haisma
Journal:  Gene Ther       Date:  2019-07-11       Impact factor: 5.250

10.  Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer.

Authors:  Lucia Natalia Moro; Diego Luis Viale; Juan Ignacio Bastón; Victoria Arnold; Mariana Suvá; Elisabet Wiedenmann; Martín Olguín; Santiago Miriuka; Gabriel Vichera
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379
View more
  2 in total

1.  Design and storage stability of reference materials for microfluidic quantitative PCR-based equine gene doping tests.

Authors:  Teruaki Tozaki; Aoi Ohnuma; Mio Kikuchi; Taichiro Ishige; Hironaga Kakoi; Kei-Ichi Hirota; Kanichi Kusano; Shun-Ichi Nagata
Journal:  J Equine Sci       Date:  2021-12-28

2.  Detection of Indiscriminate Genetic Manipulation in Thoroughbred Racehorses by Targeted Resequencing for Gene-Doping Control.

Authors:  Teruaki Tozaki; Aoi Ohnuma; Kotono Nakamura; Kazuki Hano; Masaki Takasu; Yuji Takahashi; Norihisa Tamura; Fumio Sato; Kyo Shimizu; Mio Kikuchi; Taichiro Ishige; Hironaga Kakoi; Kei-Ichi Hirota; Natasha A Hamilton; Shun-Ichi Nagata
Journal:  Genes (Basel)       Date:  2022-09-04       Impact factor: 4.141
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.